DK1274402T3 - Farmaceutisk sammensætning til kontrolleret frigivelse af paracetamol - Google Patents

Farmaceutisk sammensætning til kontrolleret frigivelse af paracetamol

Info

Publication number
DK1274402T3
DK1274402T3 DK01933832T DK01933832T DK1274402T3 DK 1274402 T3 DK1274402 T3 DK 1274402T3 DK 01933832 T DK01933832 T DK 01933832T DK 01933832 T DK01933832 T DK 01933832T DK 1274402 T3 DK1274402 T3 DK 1274402T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical composition
acetaminophen
controlled release
release phase
paracetamol
Prior art date
Application number
DK01933832T
Other languages
Danish (da)
English (en)
Inventor
Shing Yue Chan
Timothy James Grattan
Bounkhiene Sengmanee
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9890126&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1274402(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Application granted granted Critical
Publication of DK1274402T3 publication Critical patent/DK1274402T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Confectionery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK01933832T 2000-04-19 2001-04-12 Farmaceutisk sammensætning til kontrolleret frigivelse af paracetamol DK1274402T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0009522.4A GB0009522D0 (en) 2000-04-19 2000-04-19 Composition
PCT/EP2001/004302 WO2001080834A1 (en) 2000-04-19 2001-04-12 Composition

Publications (1)

Publication Number Publication Date
DK1274402T3 true DK1274402T3 (da) 2009-11-16

Family

ID=9890126

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01933832T DK1274402T3 (da) 2000-04-19 2001-04-12 Farmaceutisk sammensætning til kontrolleret frigivelse af paracetamol

Country Status (25)

Country Link
US (2) US7943170B2 (cs)
EP (1) EP1274402B1 (cs)
JP (1) JP2003531165A (cs)
KR (1) KR100845660B1 (cs)
CN (1) CN100335046C (cs)
AT (1) ATE438388T1 (cs)
AU (2) AU2001260212C1 (cs)
BR (1) BR0110129A (cs)
CA (1) CA2406373C (cs)
CO (1) CO5280073A1 (cs)
CY (1) CY1109483T1 (cs)
CZ (1) CZ303275B6 (cs)
DE (1) DE60139462D1 (cs)
DK (1) DK1274402T3 (cs)
EA (1) EA006103B1 (cs)
ES (1) ES2329971T3 (cs)
GB (1) GB0009522D0 (cs)
HK (1) HK1053601A1 (cs)
HU (1) HU230033B1 (cs)
MX (1) MXPA02010347A (cs)
NZ (1) NZ521799A (cs)
TW (1) TWI282286B (cs)
UA (1) UA76417C2 (cs)
WO (1) WO2001080834A1 (cs)
ZA (1) ZA200208084B (cs)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0009522D0 (en) * 2000-04-19 2000-06-07 Smithkline Beecham Plc Composition
TWI319713B (en) 2002-10-25 2010-01-21 Sustained-release tramadol formulations with 24-hour efficacy
US8487002B2 (en) 2002-10-25 2013-07-16 Paladin Labs Inc. Controlled-release compositions
US20040186180A1 (en) * 2003-03-21 2004-09-23 Gelotte Cathy K. Non-steroidal anti-inflammatory drug dosing regimen
CN100348974C (zh) * 2003-09-30 2007-11-14 北京东方凯恩医药科技有限公司 一种药物组合物的检测方法
US20050095299A1 (en) * 2003-10-30 2005-05-05 Wynn David W. Controlled release analgesic suspensions
CA2616204C (en) 2005-09-09 2015-12-01 Labopharm Inc. Sustained drug release composition
US20080057122A1 (en) * 2006-08-31 2008-03-06 Aaipharma Inc. Acetaminophen pharmaceutical compositions
CA2678092C (en) * 2007-10-16 2013-07-30 Labopharm Inc. Bilayer composition for the sustained release of acetaminophen and tramadol
AU2008338207A1 (en) 2007-12-17 2009-06-25 Labopharm (Barbados) Limited Misuse preventative, controlled release formulation
US9226907B2 (en) 2008-02-01 2016-01-05 Abbvie Inc. Extended release hydrocodone acetaminophen and related methods and uses thereof
MX2010009990A (es) 2008-03-11 2010-12-15 Depomed Inc Formas de dosificación gástricas retentivas de liberación prolongada que comprenden combinaciones de un analgésico no opioide y un analgésico opioide.
US8372432B2 (en) 2008-03-11 2013-02-12 Depomed, Inc. Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic
CA2746888C (en) 2008-12-16 2015-05-12 Labopharm (Barbados) Limited Misuse preventative, controlled release formulation
PL2395840T3 (pl) * 2009-02-13 2020-09-07 Romark Laboratories, L.C. Preparaty farmaceutyczne nitazoksanidu o kontrolowanym uwalnianiu
RU2012112552A (ru) * 2009-08-31 2013-10-10 Дипомед, Инк. Удерживаемые в желудке фармацевтические композиции для немедленного и продленного высвобождения ацетаминофена
US8597681B2 (en) 2009-12-22 2013-12-03 Mallinckrodt Llc Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans
US9198861B2 (en) 2009-12-22 2015-12-01 Mallinckrodt Llc Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans
CA2835330A1 (en) * 2011-05-06 2012-11-15 Glaxosmithkline Llc Sustained release paracetamol formulations
US8741885B1 (en) 2011-05-17 2014-06-03 Mallinckrodt Llc Gastric retentive extended release pharmaceutical compositions
US9050335B1 (en) 2011-05-17 2015-06-09 Mallinckrodt Llc Pharmaceutical compositions for extended release of oxycodone and acetaminophen resulting in a quick onset and prolonged period of analgesia
US8858963B1 (en) 2011-05-17 2014-10-14 Mallinckrodt Llc Tamper resistant composition comprising hydrocodone and acetaminophen for rapid onset and extended duration of analgesia
US20140206740A1 (en) * 2011-07-30 2014-07-24 Neurovance, Inc. Use Of (1R,5S)-(+)-(Napthalen-2-yl)-3-Azabicyclo[3.1.0]Hexane In The Treatment Of Conditions Affected By Monoamine Neurotransmitters
JP6266635B2 (ja) * 2012-10-18 2018-01-24 アッヴィ・インコーポレイテッド ピリミジンジオン誘導体化合物の製剤
WO2016042570A1 (en) * 2014-09-16 2016-03-24 Suresh Pareek Extended release formulation of acetaminophen
AU2017230974B2 (en) * 2016-03-09 2022-02-03 Nls-1 Pharma Ag A mazindol IR/SR multilayer tablet and its use for the treatment of attention deficit/hyperactivity disorder (ADHD)

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2058562B (en) * 1979-09-14 1983-11-30 Beecham Group Ltd Pharmaceutical compositions containing paracetamol and ascorbic acid
US4786503A (en) * 1987-04-06 1988-11-22 Alza Corporation Dosage form comprising parallel lamine
US4820522A (en) * 1987-07-27 1989-04-11 Mcneilab, Inc. Oral sustained release acetaminophen formulation and process
EP0418596A3 (en) * 1989-09-21 1991-10-23 American Cyanamid Company Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form
US5009895A (en) * 1990-02-02 1991-04-23 Merck & Co., Inc. Sustained release with high and low viscosity HPMC
US5900425A (en) * 1995-05-02 1999-05-04 Bayer Aktiengesellschaft Pharmaceutical preparations having controlled release of active compound and processes for their preparation
US5773031A (en) * 1996-02-27 1998-06-30 L. Perrigo Company Acetaminophen sustained-release formulation
BE1011045A3 (fr) * 1997-03-14 1999-04-06 Ucb Sa Compositions pharmaceutiques pour la liberation controlee de substances actives.
FR2766708B1 (fr) * 1997-07-30 2000-05-05 Galenix Dev Composition contenant de l'hydroxypropylcellulose, de l'hydroxypropylmethylcellulose et/ou de l'ethylcellullose a titre d'agents desintegrants, et procede d'obtention
US5945123A (en) * 1998-04-02 1999-08-31 K-V Pharmaceutical Company Maximizing effectiveness of substances used to improve health and well being
US6254891B1 (en) 1998-09-03 2001-07-03 Ascent Pediatrics, Inc. Extended release acetaminophen
US6126967A (en) 1998-09-03 2000-10-03 Ascent Pediatrics Extended release acetaminophen particles
GB0009522D0 (en) * 2000-04-19 2000-06-07 Smithkline Beecham Plc Composition
US7897172B2 (en) * 2004-05-18 2011-03-01 L. Perrigo Company Tablets exhibiting reduced drug release variability

Also Published As

Publication number Publication date
CO5280073A1 (es) 2003-05-30
CN1426298A (zh) 2003-06-25
CN100335046C (zh) 2007-09-05
EA006103B1 (ru) 2005-08-25
HUP0300698A2 (hu) 2003-07-28
ATE438388T1 (de) 2009-08-15
US20040202716A1 (en) 2004-10-14
US20110177168A1 (en) 2011-07-21
KR100845660B1 (ko) 2008-07-10
WO2001080834A1 (en) 2001-11-01
EP1274402A1 (en) 2003-01-15
EP1274402B1 (en) 2009-08-05
ZA200208084B (en) 2003-10-08
HU230033B1 (hu) 2015-05-28
CA2406373C (en) 2010-06-29
GB0009522D0 (en) 2000-06-07
CZ303275B6 (cs) 2012-07-11
AU2001260212B2 (en) 2006-09-21
BR0110129A (pt) 2002-12-31
PL358123A1 (en) 2004-08-09
CY1109483T1 (el) 2014-08-13
EA200200954A1 (ru) 2003-04-24
DE60139462D1 (de) 2009-09-17
JP2003531165A (ja) 2003-10-21
AU2001260212C1 (en) 2020-07-16
UA76417C2 (en) 2006-08-15
CZ20023470A3 (cs) 2003-03-12
NZ521799A (en) 2004-12-24
HUP0300698A3 (en) 2004-09-28
HK1053601A1 (en) 2003-10-31
TWI282286B (en) 2007-06-11
CA2406373A1 (en) 2001-11-01
MXPA02010347A (es) 2003-04-25
US7943170B2 (en) 2011-05-17
ES2329971T3 (es) 2009-12-03
KR20030009440A (ko) 2003-01-29
AU6021201A (en) 2001-11-07

Similar Documents

Publication Publication Date Title
DK1274402T3 (da) Farmaceutisk sammensætning til kontrolleret frigivelse af paracetamol
DK1023050T3 (da) Nye formuleringer af farmakologiske midler, fremgangsmåder til fremstillingen deraf og fremgangsmåder til anvendelsen deraf
DK2158905T3 (da) Sammensætning til transdermal administration af fentanyl
DK1131070T3 (da) Farmaceutisk sammensætning til modificeret frigivelse af en insulin- sensibilisator og metformin
NO20024528L (no) Proteaseinhibitor, farmasoytisk sammensetning og anvendelse av forbindelsen
CY1112517T1 (el) Φαρμακοτεχνικες μορφες τροποποιημενης αποδεσμευσης μιας τουλαχιστον μορφης τραμαδολης
DK1282719T3 (da) Fremgangsmåde til fremstilling af dihydroxyestere og derivater deraf
AR028372A1 (es) Dispositivos de administracion de drogas de liberacion sostenida, metodos de uso y metodos de fabricacion de los mismos
NO20025592D0 (no) Kontinuerlig produksjon av farmasöytisk granulering
CY1110906T1 (el) Φαρμακευτικη συνθεση για ρινικη χορηγηση φεντανυλης
DK0991654T3 (da) Hidtil ukendte derivater af 2-(iminomethyl)aminophenyl, deres fremstilling, deres anvendelse til medikamenter og farmaceutiske præparater indeholdende samme
IS6811A (is) Lyfjafræðilegar samsetningar NMDA viðtakagerandefna
DK1334182T3 (da) Fremgangsmåde til fremstilling af ikke-bovint chymosin og anvendelse heraf
EE200200393A (et) Glüburiidi ravimkoostis
DK1349580T4 (da) Fremgangsmåde til forbedring af stabiliteten af en farmaceutisk sammensætning
DK1108424T3 (da) Matrixtablet til langvarig frisætning af
DK1465602T3 (da) Matrix-filmtablet med kontrolleret frigivelse af naturlige blandinger af konjugerede östrogener
DK1339723T3 (da) Fremgangsmåde og ester derivater anvendelige til fremstilling af cefalosporiner
ATE297760T1 (de) Pharmazeutische zusammensetzungen enthaltend terbinafin
BR0114590A (pt) Processo para a preparação de tabletes
DK1345605T3 (da) Varmformet lægemiddelsammensætning til styret afgivelse af perindopril
NO20024679D0 (no) Krystallinsk farmasöytikum
BRPI0413777A (pt) composições de modafinil
EA200201062A1 (ru) Фармацевтическая композиция на основе нестероидного противовоспалительного средства
ATE331509T1 (de) Zusammensetzung die paracetamol und niflumic säure enthält